Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0YFPJB)
| ADC Name |
Oba01
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
Oba01; HYADC-Oba01
Click to Show/Hide
|
|||||
| Organization |
Heyuan Adisis Biotech (Originator)
|
|||||
| Drug Status |
Phase 1
|
|||||
| Drug-to-Antibody Ratio |
4
|
|||||
| Structure |
|
|||||
| Antibody Name |
Zaptuzumab
|
Antibody Info | ||||
| Antigen Name |
Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Payload Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
PY-MAA-Val-Cit-PABC
|
Linker Info | ||||
| Conjugate Type |
Reactive Cysteines
|
|||||
| Combination Type |
blivedotin
|
|||||
2027 Update
The disease landscape of This ADC
2027 Update
The clinical trial pipelines of This ADC